Earnings Analyzer
Stock earnings page

Alto Neuroscience, Inc. (ANRO)

Track the next or latest earnings date for Alto Neuroscience, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

Is Alto Neuroscience, Inc. (ANRO) Stock Positioned for Growth With New Insights Into Anhedonia Treatment?
finance.yahoo.com · 5 days ago

We recently compiled a list of the 8 Best Up and Coming Pharmaceutical Stocks to Buy Now. Alto Neuroscience, Inc. (NYSE:ANRO) is one of the best up and coming stocks on our list. On June 15, ALTO highlighted the publication in Nature Medicine of Prime-Praxol, an independent randomized, ...

Is Antero Resources (AR) One of the Best Oil and Gas Stocks to Buy for the Next Decade?
finance.yahoo.com · 16 hours ago

Antero Resources Corporation (NYSE:AR) is one of the best oil and gas stocks to buy for the next decade. Antero Resources Corporation (NYSE:AR) received a rating update from Morgan Stanley on June 29. The firm cut the price target on the stock to $48 from $56 and maintained an Overweight rating ...

Buy Alto Neuroscience Inc Stock – ANRO Stock Quote Today & Investment Insights - Public.com
public.com · Recent

Looking to buy Alto Neuroscience Inc Stock? Get the latest ANRO quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.

ANRO Stock Drops 7% After Disappointing Schizophrenia Study Results – But Analyst Sees Dip As Attractive Entry Point
stocktwits.com · April 2, 2026

Alto Neuroscience’s experimental schizophrenia drug ALTO-101 failed to meet key goals in a Phase 2 study, leading to price target cuts from multiple brokerages.

ANRO Earnings: Latest Report, Earnings Call & Financials
public.com · Recent

Following the last earnings report on Mar 16, 2026, ANRO's stock price moved — from — to —.

Latest earnings date

Mar 16, 2026

Time not specified

Fiscal quarter: 2025-12-31

EPS estimate: -$0.56

Revenue estimate: N/A

Market cap: $714.30M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Mar 16, 2026 2025-12-31 Time not specified -$0.56 N/A